Waverton Investment Management Ltd reduced its position in Colgate-Palmolive (NYSE:CL) by 11.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 48,254 shares of the company’s stock after selling 6,080 shares during the period. Waverton Investment Management Ltd’s holdings in Colgate-Palmolive were worth $2,872,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently bought and sold shares of CL. Moody National Bank Trust Division acquired a new position in Colgate-Palmolive during the fourth quarter worth $94,000. Price Capital Management Inc. acquired a new position in Colgate-Palmolive during the third quarter worth $121,000. O Brien Wealth Partners LLC acquired a new position in Colgate-Palmolive during the third quarter worth $123,000. IMS Capital Management raised its position in Colgate-Palmolive by 631.6% during the third quarter. IMS Capital Management now owns 2,085 shares of the company’s stock worth $140,000 after acquiring an additional 1,800 shares during the period. Finally, SRS Capital Advisors Inc. raised its position in Colgate-Palmolive by 61.1% during the third quarter. SRS Capital Advisors Inc. now owns 2,475 shares of the company’s stock worth $166,000 after acquiring an additional 939 shares during the period. Hedge funds and other institutional investors own 74.54% of the company’s stock.

CL has been the subject of a number of research analyst reports. UBS Group set a $71.00 price objective on shares of Colgate-Palmolive and gave the stock a “buy” rating in a research report on Wednesday, October 17th. Argus restated a “buy” rating and set a $75.00 price objective (up from $72.00) on shares of Colgate-Palmolive in a research report on Tuesday, September 18th. Goldman Sachs Group upgraded shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating in a research report on Tuesday, January 8th. Morgan Stanley reduced their price objective on shares of Colgate-Palmolive from $65.00 to $60.00 and set a “hold” rating for the company in a research report on Tuesday, October 30th. Finally, Zacks Investment Research upgraded shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a research report on Tuesday, September 18th. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and four have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $67.87.

Shares of Colgate-Palmolive stock traded down $0.22 during trading hours on Monday, reaching $61.88. 537,916 shares of the company’s stock were exchanged, compared to its average volume of 4,859,508. Colgate-Palmolive has a 1 year low of $57.41 and a 1 year high of $77.91. The firm has a market capitalization of $53.17 billion, a price-to-earnings ratio of 21.56, a PEG ratio of 2.94 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, October 26th. The company reported $0.72 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a net margin of 13.55% and a return on equity of 12,004.60%. The business had revenue of $3.85 billion during the quarter, compared to analyst estimates of $3.89 billion. During the same quarter in the prior year, the firm earned $0.73 earnings per share. The company’s revenue for the quarter was down 3.2% compared to the same quarter last year. As a group, equities analysts expect that Colgate-Palmolive will post 2.96 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 15th. Stockholders of record on Wednesday, January 23rd will be issued a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.71%. The ex-dividend date is Tuesday, January 22nd. Colgate-Palmolive’s payout ratio is 58.54%.

COPYRIGHT VIOLATION NOTICE: “Waverton Investment Management Ltd Has $2.87 Million Position in Colgate-Palmolive (CL)” was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another site, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The correct version of this piece can be viewed at https://www.watchlistnews.com/waverton-investment-management-ltd-has-2-87-million-position-in-colgate-palmolive-cl/2745323.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Further Reading: How Do You Calculate Return on Investment (ROI)?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.